BOJHT
ATNM icon

Bank of Jackson Hole Trust’s Actinium Pharmaceuticals ATNM Stock Holding History

Bank of Jackson Hole Trust’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,000
Closed -$1.26K – 455
2024
Q4 		$1.26K Buy
+1,000
New +$1.55K ﹤0.01% 491

Other funds holding ATNM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $25.4B AUM 38.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of Jackson Hole Trust's ATNM Position: Q1 2025 in Review

Bank of Jackson Hole Trust sold out of Actinium Pharmaceuticals (ATNM) in Q1 2025, closing a stake of 1,000 shares — an estimated $1.26K sold.

Bank of Jackson Hole Trust first reported a position in ATNM in Q4 2024 and held it in 1 quarter. The position peaked at $1.26K in Q4 2024. 69 funds tracked by Wall St. Rank hold ATNM as of Q1 2025.

  • Bank of Jackson Hole Trust reported no remaining Actinium Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Bank of Jackson Hole Trust sold 1,000 Actinium Pharmaceuticals shares in Q1 2025, an estimated $1.26K.
  • Bank of Jackson Hole Trust first reported a position in Actinium Pharmaceuticals in Q4 2024 and held it in 1 quarter.
  • Bank of Jackson Hole Trust's Actinium Pharmaceuticals position peaked at $1.26K in Q4 2024.
  • 69 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q1 2025.

Based on Bank of Jackson Hole Trust's 13F filing for Q1 2025, filed 8 May 2025.